Q&A: Advocate Health CNIO on AI Implementation Best Practices for Nursing
Advocate Health’s chief nursing informatics officer outlines how ambient AI documentation is being rolled out to cut nursing clicks and reduce documentation fatigue. A pilot showed 65% of caregivers used the tool six or more times per shift, with more than 80% reporting meaningful time savings and less after‑hours charting. The organization relies on a FAIR‑AI governance framework and stresses nurse involvement in design to build trust and ensure safe, unbiased adoption. AI is positioned to shift nurses’ focus from administrative tasks to direct patient care.
Northwestern Medicine's Journey in Scaling Up the Collaborative Care Model
Northwestern Medicine has scaled its Collaborative Care Model to all 70 primary‑care clinics, reaching roughly 500 physicians. The effort began with mandatory depression screening a decade ago and grew through a partnership with the Department of Psychiatry and West Health’s...
HopeHealth’s New Academic Partnership a ‘Nexus’ of Hospice Leader Development
HopeHealth has formalized an academic practice partnership with the University of Rhode Island’s College of Nursing to expand hospice and palliative‑care training. The collaboration provides nursing students with advanced clinical rotations, research opportunities for doctoral candidates, and guest lectures from...
Why the Ebola Outbreak Is Worrying Public Health Officials
The World Health Organization has declared a Bundibugyo‑strain Ebola outbreak a public health emergency of international concern after 30 confirmed cases in the Democratic Republic of Congo and two in Uganda, with more than 500 suspected infections. The strain lacks...
How Ochsner Turned Telemedicine Into a Hospital Lifeline
Ochsner Health launched its first telemedicine program in 1998 and expanded into tele‑stroke in 2009, laying a 25‑year foundation for virtual care. The system later unified disparate pilots into a centralized, standardized virtual‑care operating model that pairs virtual clinicians with...
CDC Provides Update on Hantavirus Outbreak Linked to M/V Hondius Cruise Ship
On May 18, 2026, the CDC announced that 18 U.S. passengers repatriated from the M/V Hondius cruise ship will remain in a Nebraska quarantine facility until May 31, marking the end of a 21‑day monitoring period. Since disembarkation, three additional...
BioMarin Drug Acquired in Buyout Misses Goal in Rare Disease Study
BioMarin Pharmaceutical’s BMN 401, an enzyme‑replacement therapy for ENPP1 deficiency, met its primary biochemical endpoint by raising plasma PPi levels but failed the co‑primary skeletal health goal in a Phase 3 trial of 27 children. The miss on clinical benefit and all...
JCR Pharmaceuticals Highlights Preclinical CNS Gene Therapy Data for JUST-AAV Platform at ASGCT 2026
JCR Pharmaceuticals showcased preclinical data for its JUST‑AAV platform at ASGCT 2026, highlighting enhanced central nervous system (CNS) delivery and reduced liver exposure compared with conventional AAV9 vectors. The platform uses transferrin‑receptor‑targeted capsids to cross the blood‑brain barrier, delivering therapeutic...
Malaysia, Singapore Expand Strategic Healthcare Ties
Malaysia and Singapore are deepening strategic healthcare cooperation, covering food‑labelling alignment, faster medical‑device approvals and expanded cross‑border health tourism. Health ministers signed an MOU in Geneva, pledging joint action on non‑communicable diseases and shared public‑wellbeing goals. Malaysia welcomed Singapore’s Medical...
Medtronic, BD Name New Leaders
Medtronic announced that Kweli Thompson, currently president of its cardiac rhythm management division, will become president of the company's neuroscience portfolio on June 1, succeeding Brett Wall, who will depart by Sept. 1 and resign from the MiniMed board in July. Scott Cundy, Medtronic’s...
Commure Raises $70M, Boosting Post-Money Valuation to $7B
Commure, the AI‑enabled healthcare software firm, secured a $70 million financing round, lifting its total capital raised to $750 million and its post‑money valuation to $7 billion. The round was led by General Catalyst with participation from Sequoia Capital, Morgan Stanley and Kirkland...
Lessons Learned From Drug Development Programs in Autism: Implications for Future Programs
The article synthesizes expert insights on why autism drug development has lagged, highlighting the lack of approved therapies for core symptoms and the challenges posed by biological and clinical heterogeneity. It outlines six key learnings, including the need to measure...
OpenBind Unveils Its First AI Model for Drug Discovery
OpenBind, a UK‑led consortium, has published its first AI‑ready dataset and a predictive model for the EV‑A71 2A protease, a target linked to hand, foot and mouth disease. The release includes 699 X‑ray structures and binding‑strength data for 601 compounds,...
Wave Aims for Monthly Dosing with RNA Editing Treatment for AATD
Wave Life Sciences announced an updated read‑out from its early‑stage trial of an RNA‑editing therapy for alpha‑1 antitrypsin deficiency (AATD). The data indicate that the treatment can restore functional protein levels with a dosing schedule that could be moved to...
This Ebola Outbreak Will Be Hard to Contain
The Democratic Republic of Congo confirmed a new Ebola outbreak that has already sickened more than 500 people and killed over 130, spreading to Uganda. The virus is the Bundibugyo strain, which evades standard rapid tests and lacks approved vaccines...
Century Health Raises $5M for CHARM AI Platform to Accelerate Life Sciences Research
Century Health announced an oversubscribed $5 million seed round led by Origin Ventures, bringing its total funding to a strategic level. The company’s CHARM AI platform automates extraction of unstructured electronic health record data with a validated 97% accuracy rate. Over...
Gifthealth Delivers Off-The-Shelf Solution to Deliver MFN Pricing
Gifthealth, the nation’s largest direct‑to‑patient (DTP) partner, announced an off‑the‑shelf solution that enables manufacturers to offer most‑favored‑nation (MFN) pricing within as little as 21 days. The platform, which already handles more than 90% of U.S. DTP volume, supports high‑volume drugs...
Implement AI in the Mid-Cycle of Rev Cycle for the Biggest Return
Methodist Health System partnered with AKASA to embed an AI coding optimizer in its revenue‑cycle mid‑stage, allowing claims to be reviewed before submission. The tool cut payment turnaround from 90‑120 days to 30‑45 days, generating an extra $120,000‑$150,000 per month....
3 in 4 Compromised Healthcare Devices Expose Patient Records, Flare Report Reveals
Flare’s 2026 State of Healthcare Credential Exposure report documents a 33% year‑over‑year surge in compromised healthcare credentials, with nearly three‑quarters of infected devices leaking EHR/EMR logins. The United States accounts for 48% of all healthcare‑related credential logs surfaced on underground...
Validation Studies, Clinician Verification Keep Ambient AI Accurate
Wendy Charles of the University of Denver and Renee Pratt of the University of North Georgia detail a framework of safeguards that health systems can deploy to keep ambient AI‑generated clinical notes accurate. Their recommendations stress rigorous validation studies, mandatory...
More Good News for Boston Scientific’s Coronary IVL Tech
Boston Scientific reported strong early results from its single‑arm FRACTURE trial of the Seismiq 4CE coronary intravascular lithotripsy (IVL) catheter. Freedom from major adverse cardiac events at 30 days was 93.3%, well above the 86.2% target, and procedural success hit 93.7%...
How Rwanda Is Using Drones to Improve Health Care
In 2016 Rwanda partnered with Zipline to launch drone ports that deliver blood products to hospitals, turning multi‑hour trips into 15‑60‑minute drops. A Wharton‑led study shows the program cut postpartum hemorrhage deaths by 51% and trauma deaths by 30%, while...
Anthropic’s Mythos Threatens Healthcare Cybersecurity: 6 Updates
Anthropic’s Claude Mythos preview can autonomously discover and exploit zero‑day vulnerabilities across major operating systems and browsers, a leap in AI‑driven cybersecurity. Researchers found thousands of previously unknown flaws before the model’s restricted release, and even users with limited training...
HCA Florida Hospital Names CEO
HCA Healthcare appointed Philip Marchesini as CEO and market lead of HCA Florida Fawcett Hospital in Port Charlotte. Marchesini previously led HCA Florida Northside Hospital and held COO roles at Largo and St. Peterburg facilities. He succeeds Michael Ehrat, who moves...
Emory Launches ED Nurse Residency Program
Emory Decatur Hospital has launched the health system’s first emergency department nurse residency, the inaugural Emergency Nurses Association program in the Atlanta region. The year‑long curriculum blends clinical education, bedside training and mentorship, beginning with a 16‑week orientation that includes...
Re: UK Alcohol Deaths Fall for First Time Since Pandemic, but Experts Highlight “Stark Inequalities”
UK alcohol‑specific deaths fell for the first time since the pandemic, yet they remain above pre‑COVID levels. The decline masks stark socioeconomic gaps: men in the most deprived neighborhoods are four times more likely to die from alcohol than those...
13 Healthcare Organizations Moving to Epic
Epic solidified its dominance in the U.S. acute‑care EHR market in 2024, capturing 42.3% of hospitals and 54.9% of beds. The KLAS report shows the vendor added a record net gain as ten health systems selected Epic for 108 hospitals,...
Virginia Health System Names New Chief Digital Officer
Centra Health announced Sanjeev Sah as its senior vice president and chief digital and information officer, a role that will steer the Virginia‑based system’s IT and digital transformation. Sah, who posted the news on LinkedIn on May 19, brings experience as...
20 Large Health Systems Growing Bigger
Hospital consolidation is gaining momentum after a brief post‑pandemic pause, with large health systems pursuing cross‑state mergers, acquisitions and strategic partnerships. Twenty major systems announced or plan deals this year, ranging from Atrium Health’s combination with WakeMed to Sutter Health’s...
Hospitals Freeze Jobs in April
Hospital employment stalled in April, with the Bureau of Labor Statistics reporting zero net hires— the first flat month since June 2021. Seasonal adjustments modestly added 4,300 positions, but the broader healthcare sector still created 37,000 jobs, driven by nursing...
Brain Scans Reveal How Ibogaine Alters Neural Networks in Veterans with Head Trauma
Researchers at Stanford reported that a single dose of ibogaine, combined with magnesium, produced measurable neurobiological changes in 30 combat veterans with mild‑to‑moderate traumatic brain injury and PTSD. Functional MRI scans revealed sustained increases in cerebral blood flow across the...
Contractors Lined up for Specific New Hospital Programme Jobs
The NHS has earmarked ten contractors for the first £15 bn wave of its New Hospital Programme under the Hospital 2.0 Alliance framework. The list includes Graham for Airedale, Willmott Dixon for Royal Cornwall, Sacyr UK for Frimley Health, and others, with...
Aetna’s Chief Digital and Technology Officer on How the Insurer Is Using AI for Patient Engagement
Aetna, owned by CVS Health, has launched a conversational AI assistant and a condition‑specific product called Care Paths to simplify member navigation of benefits and care. The AI tools provide natural‑language answers, map providers, and suggest next‑best actions, while also...
Address Clinical and IT Needs First to Help Ensure Ambient AI Success
Wendy Charles of the University of Denver and Renee Pratt of the University of North Georgia warn that while ambient AI can dramatically speed clinical documentation, it also raises accuracy and integration challenges. They argue that success hinges on addressing...
EMA Marketing Authorization of New Drugs in April 2026
In April 2026 the European Medicines Agency granted marketing authorizations and CHMP positive opinions for a slate of new therapies spanning infectious disease, neurology, immunology, endocrinology and rare disorders. Merck’s Enflonsia monoclonal antibody reduced RSV‑related hospitalizations by 84% in infants,...
Everyone’s Betting on AI to Solve the Physician Shortage —They’re Solving the Wrong Problem
The U.S. healthcare debate frames physician shortages as a supply issue, prompting more residency slots and medical‑school expansions. Recent McKinsey and Deloitte surveys, however, show that the real constraint is distribution—administrative friction keeps trained doctors from working where needed. About...
Lus Essentials LLC - 728783 - 05/14/2026
The FDA issued a warning letter to Lus Essentials LLC on May 14, 2026 after laboratory analysis revealed that its skin‑treatment products contain high levels of mercury. The agency classified the items as unapproved new drugs and misbranded drugs under...
La Crema De Rebeca - 728782 - 05/14/2026
The FDA issued a warning letter to La Crema De Rebeca after laboratory analysis revealed high mercury levels in its skin‑treatment cream. The agency classified the product as an unapproved new drug and a misbranded drug because its labeling omitted...
JW Nutritional LLC - 722096 - 04/15/2026
The FDA issued a Warning Letter to JW Nutritional LLC after a September 2025 inspection uncovered multiple CGMP violations at its McKinney, Texas facility. The firm failed to perform identity testing on incoming high‑risk components, lacked validated process controls, and...
Harbin Jixianglong Biotech Co., Ltd. - 723330 - 05/01/2026
The FDA issued a warning letter to Harbin Jixianglong Biotech after a November 2025 inspection revealed multiple CGMP violations involving its peptide API manufacturing. The firm repackaged and relabeled semaglutide batches from unapproved suppliers, misbranding the products and failing to...
PolleyMed, LLC - 726018 - 05/14/2026
The FDA issued a warning letter to PolleyMed, LLC for marketing its SaniiSwab™ nasal cleaning product as an unapproved new drug and for misbranding claims of FDA OTC approval. The agency’s review of the company’s website and social‑media content found...
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences - 724881 - 04/29/2026
The FDA issued a warning letter to Dr. Sourav K. Mishra of AIIMS Bhubaneswar for serious violations in a bioequivalence study of doxorubicin hydrochloride liposome injection conducted for Qilu Pharmaceutical. The investigator administered the prohibited CYP3A4 inhibitor aprepitant to all...
The Future of Healthcare Screenings: The Power of Vocal Biomarkers
Vocal biomarkers—AI‑driven analysis of a 40‑second voice sample—are emerging as a rapid, non‑invasive screening tool for conditions ranging from mild cognitive impairment and Alzheimer’s to depression, anxiety, Parkinson’s and multiple sclerosis. Recent studies, including a Japanese trial of 1,461 seniors,...
Teen Temptations Beware: MAHA-Era FDA Gives Vapes, Tanning Beds a Boost
The FDA has authorized its first fruit‑flavored vaping products for adult use while signaling it will not prioritize enforcement against many unauthorized vapes and nicotine pouches still under review. At the same time, the agency withdrew a proposed ban on...
Why AI’s Healthcare Promise Is Stalling
Healthcare providers are amassing massive data streams, yet many struggle to turn that information into actionable insights. Health Catalyst’s Chief Product Officer Robbie Hughes argues that the AI promise stalls because organizations focus on new models instead of solid data...
A Match Made in Heaven: Has Your Blood Collection Tube Been Appropriately Validated with Your Assays?
Blood‑collection tubes are FDA‑cleared in‑vitro diagnostic devices, but their clearance does not confirm compatibility with every clinical assay or analyzer. CLSI guideline GP34‑A places the burden of full validation on manufacturers while laboratories are responsible for verification of tube‑assay combinations....
Bipartisan Bill Aims to Break Pharmacies Away From Health Insurers and PBMs
Congress is reintroducing the Patients Before Monopolies Act, a bipartisan bill that would require health insurers and pharmacy‑benefit managers (PBMs) to divest any pharmacies they own. The legislation is led in the Senate by Elizabeth Warren and Josh Hawley and...
Why some People Skip the Closest Pharmacy—And What that Means for Health Care Deserts
A new study from Cal Poly, published in Risk Analysis, reveals that Americans often skip the nearest pharmacy, choosing locations that match the socioeconomic character of their neighborhoods. While 98% of Los Angeles County residents live within 5 km of a pharmacy,...
FDA Approves First-Ever Gene Therapy For Deafness, Opening Door To New Era
The U.S. Food and Drug Administration has approved the world’s first gene therapy for deafness, targeting the OTOF mutation that blocks sound transmission in the inner ear. In a pivotal trial of 20 children and teens, 80% experienced improved hearing...
SERB to Pay Hansa €110M Upfront for EU Rights to Kidney Transplant Drug
SERB Pharmaceuticals will pay Hansa Biopharma €110 million (≈$119 million) upfront for exclusive rights to Idefirix across Europe, the Middle East and North Africa. The antibody‑cleaving enzyme, conditionally approved for highly sensitized kidney‑transplant patients, generated €18.7 million (≈$20 million) in 2025 sales but has...